In the tumor tissues of the AA and anti-PD1 co-treatment group, the number of granzyme B-positive cells was significantly higher than that in the AA alone or anti-PD1 treatment groups (Figures 3C, D). This evidence concerns the gene PDCD1 and neoplasm.